Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Gene may protect against heart disease rather than be harmful as previously thought

28.11.2003


A genetic pathway whose activity was suspected to advance heart disease by increasing inflammation in the blood vessels and arteries feeding the heart may actually protect against it at least in laboratory mice, reports a team of Rockefeller University scientists led by Jan Breslow, M.D., in the Nov. 25 issue of Proceedings of the National Academy of Sciences.



The Rockefeller scientists’ findings that blocking the NFkB pathway actually contributes to heart disease in the lab animals, occurred as part of their larger study to identify mechanisms of heart disease that are unrelated to one of the primary risk factors for the disease: high blood levels of "bad" cholesterol and low levels of "good" cholesterol.

"Having high cholesterol increases your risk, but does not mean that you will get heart disease," explains Susanne Idel, Ph.D., the Rockefeller scientist who is the lead author of the PNAS paper. "There are people who smoke, who are overweight, or who eat badly, and whose blood vessels and arteries don’t become obstructed by the fatty build-up called plaques.


"So, there must be genetic pathways other than those connected to cholesterol metabolism. Our research has identified a non-cholesterol related gene that is linked to the development of heart disease in mice."

Understanding the actions of the NFkB (Nuclear Factor Kappa-B) pathway may suggest new treatment approaches against heart disease, the number one killer of adult men and women in the United States.

"Right now, the main ways we have to prevent heart disease relate to cholesterol, blood pressure and other risk factors for heart attack," says Idel. "In the long term, our hope is that we will have a more complex understanding of the genetics involved that gives us new tools for treating heart disease."

In the recent study, Idel, Breslow and co-author Hayes M. Dansky, M.D. (Cardiovascular Institute, Mt. Sinai School of Medicine) focused on the NFkB pathway and the A20 gene that regulates this pathway. NFkB, a protein that controls the inflammatory response, is activated as part of the body’s natural response to the fatty streaks that accumulate in the blood vessels and arteries as the first stage of heart disease. The inflammatory response is not exclusive to these fatty streaks, also called atherosclerotic plaques, but is generally activated when tissue is damaged by harmful agents such as viruses, bacteria, chemicals or physical trauma. In response to the inflammation, the tissue lining the blood vessels and arteries change in ways associated with inflammation. The mechanism of NFkB regulation by A20 is not related to any of the known cholesterol pathways.

Because the NFkB pathway turns on inflammatory genes and inflammation is associated with atherosclerosis, some scientists have focused on this pathway as one route that promotes heart disease. But mounting evidence suggests that the reverse may be true. Several research groups have created mice in which the pathway has been disabled and the animals’ blood vessels and arteries have actually less atherosclerosis.

"The idea that NFkB has an anti-atherosclerotic effect is controversial," says Idel. "But, if it were true that the pathway had only harmful effects, then turning it off should have protected the mice. This is not what we have observed."

"NFkB does turn on inflammatory genes," continues Idel, "but you can’t disregard that it also turns on other genes that may be important for cell survival. It regulates genes that promote anti-inflammatory and anti-cell death mechanisms. These other genes are important, too, and they may have a protective effect. Thus it might be beneficial if the NFkB pathway remains active longer for its anti-inflammatory and anti-cell death related effects."

Substantiating this view are findings from the Breslow lab published in the PNAS paper. The scientists discovered that two strains of mice exhibit genetic differences in the A20 gene, which cause them to shut down the NFkB pathway at different speeds. Mice that turn off NFkB less efficiently have less severe atherosclerosis.

The Breslow team’s track record in heart disease research is extensive. For example, the lab pioneered the mouse model of heart disease, thereby providing the scientific community with a non-human animal to study disease genetics in a controlled fashion that can render discoveries relevant for the human condition. Atherosclerosis does not normally occur in mice, but was modeled for the first time in the mouse by the Breslow team by knocking out, or deleting, a gene called Apo E. These mice are known as Apo E knockout mice.

The severity of atherosclerotic disease is seen in varying degrees among different strains of Apo E knockout mice. Genetic differences cause them to have different ranges of disease as indicated by the size of the fatty lesions in the blood vessels and arteries.

In a prior study, the Breslow group compared the genetic make-up of two strains of Apo E knockout mice whose atherosclerotic fatty obstructions differed in degree of severity. They were searching for stretches of DNA that some mice with less severe lesions had inherited in common. From this study, they identified a locus, or area in the mouse genome, linked to the size of atherosclerotic lesions. With other variables controlled for, the mice with one version of the locus would get two times as much atherosclerosis as the mice with the other version. The study’s authors concluded that some variation in the genes at this locus must cause the observed athero-protective effect.

The Breslow team identified A20 as a candidate gene for the athero-related observations for three reasons. First, it is within the locus of interest, located on chromosome 10. Second, it regulates NFkB. Third, and this part is key, its basic structure in the athero-protected mice differs slightly from the A20 in the athero-prone mice. The two versions differ by one amino acid. This is called a point mutation.

Genetic mutations can be "silent" when they have no effect, but in this case, the variation has a demonstrable effect. The A20 proteins produced have slightly different structures and they demonstrate different regulation patterns. As result, NFkB remains active for different amounts of time in the two strains of mice.

The scientists believe A20 works this way. NkB turns A20 on. Once A20 becomes activated, it turns NFkB off, thereby stopping the process of its own activation. This is called feedback inhibition. But, the version of A20 correlated with reduced atherosclerosis turns NFkB off less effectively. As a result, NFkB remains active longer and targets of NFkB, the genes it activates, also demonstrate prolonged activity. In light of the previous study, prolonged NFkB activity in mice is linked with reduced atherosclerosis.

The studies authors are careful to say that while their results are interesting, the NFkB story is incomplete.

"The NFkB pathway turns on some genes that would be expected to ameliorate atherosclerosis and some genes that make it worse," says Idel. "In the mice, an active pathway seems to be preferable, but more research is required to determine how the effects balance out. There is still much that is unknown about the genetics of heart disease, but A20 and the NFkB pathway offer promising leads worthy of more study."


This research was supported in part by grants from the National Institutes of Health and the German Academic Exchange Service.

Joseph Bonner | EurekAlert!
Further information:
http://www.rockefeller.edu/

More articles from Life Sciences:

nachricht How gut bacteria can make us ill
18.01.2017 | Helmholtz-Zentrum für Infektionsforschung

nachricht Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs
16.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>